Menu
  • About
    • Who we are
    • What we do
    • Why to work with us
    • Career
    • Contacts
    • Legal Notice
    • Anti-Bribery & Anti-Corruption Policy
  • Experience
    • Consumer Healthcare / OTC Consulting
    • Pharma Consulting
    • Medical Device Consulting
    • Cosmetics / Derma Consulting
    • Food Supplements Consulting
    • Pharma M&A Consulting
    • Pharma Wholesale Consulting
    • Pharma Retail Consulting
    • Pharma Production & Contract Manufacturing Consulting
  • Services
    • Services Overview
    • International Strategy
    • Market Entry
    • Partner Company Identification
    • Product & Country Analysis
    • Licensing & M&A
    • Regulatory & Registration
    • Pharma Executive Search
  • Publications
    • Pharma Market Reports
    • Local Market Studies & Analyses
    • WEM News
    • Country Pharma Market Data
    • CPC Personal Expert Interviews
  • Country Pharma Market Data
  • Contacts
  • English
    • Deutsch
    • Русский
    • Español
    • Português

Portfolio Analysis

CPC Portfolio Analysis

 

The Key Benefi­ts from our CPC Portfolio Analysis and Management Approach

In formal terms, a ‘portfolio analysis’ is a study of the performance of specific portfolios under different circumstances, including strategies for achieving the best trade-offs between potential risks and returns.

With regards to healthcare, the approach can be very different. Within the Pharma Rx. OTC and Medical Device Market, business managers may wish to receive the results of a portfolio analysis about R&D pipeline products because most of their costs and capital have centred in this area.

The necessity of a portfolio analysis of marketing costs before launching or pushing a new or pre-existing brand might be one of the biggest questions coming from management in OTC and Cosmetic Markets. Moreover, this kind of portfolio analysis could also create a good amount of transparency when comparing countries and business units, as well as before entering into new markets or launching new products.

The key benefi­ts from our CPC Portfolio Analysis Approach are:

–         Shedding light on your poor dogs, stars, cash cows and question marks

–         Offering detailed analyses of markets five years in the future

–         Insights as to where to place future investments and marketing focuses

–         Better profits in terms of spending rates due to an optimised portfolio

–         Understanding of how you relate to the competition

–         And more…

Generic selectors
Exact matches only
Search in title
Search in content
  • Contact

    Chameleon Pharma Consulting
    A Business of Mammut Pharma GmbH
    Am Tempelhofer Berg 6
    10965 Berlin
    Phone: +49 30 648 35 164
    Fax: +49 30 648 32 008
    service@chameleon-pharma.com

  • Insider Magazine

    • US Pharma
    • China Pharma
    • Country Pharma Market Data
    • Indonesia Pharma
    • Russia Pharma
    • Mexico Pharma Market
    • Germany: The biggest European market
  • Important Facts

    • Pharma Consulting
    • Consumer Healthcare / OTC Consulting
    • Medical Device Consulting
    • Food Supplements Consulting
    • Pharma Regulatory & Registration
    • Pharma Executive Search
    • International Pharma Strategy
    • Pharma M&A Consulting
    • Health Care Consulting
  • Menu

    Sitemap
    About
    Experience
    Services
    Publications
    Countries
    Market Reports
    Privacy Policy
    Contact
    Legal Notice

©2020 Chameleon Pharma Consulting